Akari Therapeutics: Akari Therapeutics, Plc Reports Earnings Results for the Full Year Ended December 31, 2024
Akari Therapeutics, Plc reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 19.79 million compared to USD 10.01 million a year ago. Akari Therapeutics, Plc reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 19.79 million compared to USD 10.01 million a year ago.
Read full article »
Akari is an England-based biotechnology company that researches and develops novel therapeutics for the treatment of autoimmune and inflammatory diseases.
Read more